Featured
-
-
Comment |
Patent fixes for Europe
The continent's patent system is Byzantine, but current proposals for a new EU-wide patent could make matters worse, warns Bruno van Pottelsberghe de la Potterie.
- Bruno van Pottelsberghe de la Potterie
-
Correspondence |
Clarifying knowledge ownership in Europe's medicines initiative
- Kim De Rijck
- & Michel Goldman
-
News |
Universities shun Europe's drug initiative
Intellectual-property rules push researchers away.
- Natasha Gilbert
-
News |
Start-up model patently flawed
Study shows more US professors go into business as consultants than as inventors.
- Zoë Corbyn
-
News |
DNA patent ruling hinders Monsanto
Lawyers debate a European court decision on patents involving genetic material.
- Richard Van Noorden
-
News |
US Supreme Court avoids clarifying patent stance
A highly anticipated case yields disappointingly vague results.
- Heidi Ledford
-
-
News |
Publisher seeks patent
Scientist applies to protect online reviewing and journal-publishing process.
- Declan Butler
-
News |
Green patents corralled
Intellectual-property database could ease technology transfer.
- Quirin Schiermeier
-
Editorial |
Testing time for gene patents
A surprising US court decision highlights the need to modernize gene-patenting practices if patients are to benefit from advances in genetic research.
-
News |
Breast cancer gene patents judged invalid
Court ruling may spell bad news for biotech industry.
- Meredith Wadman
-
Books & Arts |
Theft or innovation?
A history of intellectual-property rights reveals how the pirating of ideas and goods has transformed science publishing, drug development and software, explains Michael Gollin.
- Michael Gollin
-
News |
China's patents push
Asia defies patent-filing downturn as global economy slips.
- David Cyranoski
-
News |
Lawsuit rekindles gene-patent debate
Criticism of exclusive licences puts university policies in the spotlight.
- Brendan Borrell